FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SMHB
ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B Stock AnalysisComprehensive stock analysis for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B (SMHB) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSMHB
SMHB
ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SMHB
Home🔹Stocks🔹ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B

ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B

🇺🇸SMHB•AMEX

ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B

🇺🇸SMHB•AMEX
Market cap
$18.17M
Sentiment

Your view on SMHB

Mkt Cap
$18.17M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B

Industry
Asset Management - Leveraged
Sector
Financial Services
CEO
Not available
Headquarters
US
Industry
Asset Management - Leveraged
Sector
Financial Services
CEO
Not available
Headquarters
US
Description

The index is designed to measure the performance of 100 relatively small capitalization, dividend yielding index constituent securities selected from a universe of qualifying U.S. listed equity securities.

The Securities are two times leveraged with respect to the index and, as a result, will benefit from two times any beneficial, but will be exposed to two times any adverse, compounded monthly performance of the index.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B, and the rating behind it. SMHB last traded at $3.50; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. Starting points for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B: beta 1.69 — an Asset Management - Leveraged name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B paid $0.74 per share over the last year — a 21.0% yield at the current $3.50 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B valued side by side against its closest peers. ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B is measured against Asset Management - Leveraged peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Which institutions hold ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B, and how their positions are changing. At a $18.2M market value, institutional positions materially move ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

Buying and selling by ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B executives and directors. Shares of ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B have traded between $3.17 and $5.53 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B is a $18.2M Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

Latest headlines and company announcements for ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B. Coverage tracks ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B within Asset Management - Leveraged (Financial Services). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN Series B.

Peer companies

  • AUMIThemes Gold Miners ETF
  • ERYDirexion Daily Energy Bear 2X Shares
  • HDGProShares - Hedge Replication ETF
  • JANZTrueShares Structured Outcome (January) ETF
  • JPSVJPMorgan Active Small Cap Value ETF
  • MSFLGraniteShares 2x Long MSFT Daily ETF
  • QTJLInnovator Growth Accelerated Plus ETF
SMHB Analysis
Weak
Past1
Growth1
Health1
Profit1
Value1

News

Latest Market News